FDA Approves Return Of Non-Prescription Asthma Inhaler After 7 Years Seven years after it was taken off the market, asthma inhaler Primatene may now be purchased again for asthma relief. The new version no longer contains ozone-depleting CFC propellants. by Athena Chan